retatrutide compound pharmacy Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide and the Grey Market:

Recombinant Human LR3 Insulin Like Growth Factor-1 produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 83 amino acids and having a molecular mass of 9.1kDa

Offering a modern weight loss benefit especially one that reduces medication dependency gives employers a way to reduce high-cost chronic condition claims, improve productivity and morale, attract and retain health-conscious talent, and address a root cause of rising healthcare costs

E.Van HorssenJ

With dose reduction, the timeline is not well documented but would be expected to fall somewhere between discontinuation and continued use